{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T04:32:24Z","timestamp":1789187544620,"version":"build-2803163510"},"reference-count":30,"publisher":"WHO Press","issue":"11","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Bull. World Health Organ."],"published-print":{"date-parts":[[2016,11,1]]},"DOI":"10.2471\/blt.15.168765","type":"journal-article","created":{"date-parts":[[2016,10,31]],"date-time":"2016-10-31T10:39:58Z","timestamp":1477910398000},"page":"850-855","source":"Crossref","is-referenced-by-count":18,"title":["Dengue vaccine: local decisions, global consequences"],"prefix":"10.2471","volume":"94","author":[{"given":"Hugo","family":"L\u00f3pez-Gatell","sequence":"first","affiliation":[{"name":"National Institute of Public Health, Avenida Universidad 655, Santa Mar\u00eda Ahuacatitl\u00e1n, Cuernavaca, 62100, Mexico."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Celia M","family":"Alpuche-Aranda","sequence":"additional","affiliation":[{"name":"National Institute of Public Health, Avenida Universidad 655, Santa Mar\u00eda Ahuacatitl\u00e1n, Cuernavaca, 62100, Mexico."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 I","family":"Santos-Preciado","sequence":"additional","affiliation":[{"name":"Division of Experimental Medicine, National Autonomous University of Mexico, Mexico City, Mexico."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mauricio","family":"Hern\u00e1ndez-\u00c1vila","sequence":"additional","affiliation":[{"name":"National Institute of Public Health, Avenida Universidad 655, Santa Mar\u00eda Ahuacatitl\u00e1n, Cuernavaca, 62100, Mexico."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1305","published-online":{"date-parts":[[2016,9,7]]},"reference":[{"issue":"9966","key":"key-10.2471\/BLT.15.168765-201610311139-R1","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1016\/S0140-6736(14)60572-9","article-title":"Dengue.","volume":"385","author":"Guzm\u00e1n","year":"2015","journal-title":"Lancet"},{"key":"key-10.2471\/BLT.15.168765-201610311139-R2","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1007\/978-3-7091-1422-3_11","author":"Lopez-Gatell","year":"2015","journal-title":"Neglected tropical diseases - Latin America and the Caribbean."},{"key":"key-10.2471\/BLT.15.168765-201610311139-R3","unstructured":"Sanofi Pasteur dengue vaccine approved in Costa Rica. Lyon: Sanofi Pasteur; 2016. Available from: http:\/\/www.sanofipasteur.ca\/node\/49001 [cited 2016 Jun 21]."},{"issue":"21","key":"key-10.2471\/BLT.15.168765-201610311139-R4","first-page":"266","article-title":"Meeting of the Strategic Advisory Group of Experts on Immunization, April 2016 \u2013 conclusions and recommendations.","volume":"91","year":"2016","journal-title":"Wkly Epidemiol Rec"},{"key":"key-10.2471\/BLT.15.168765-201610311139-R5","unstructured":"Background paper on dengue vaccines. Geneva: Strategic Advisory Group of Experts Working Group on Dengue Vaccines; 2016. Available from: http:\/\/www.who.int\/immunization\/sage\/meetings\/2016\/april\/1_Background_Paper_Dengue_Vaccines_2016_03_17.pdf [cited 2016 Aug 16]."},{"issue":"9951","key":"key-10.2471\/BLT.15.168765-201610311139-R6","doi-asserted-by":"publisher","first-page":"1358","DOI":"10.1016\/S0140-6736(14)61060-6","article-title":"Clinical efficacy and safety of a novel tetravalent dengue vaccine in healthy children in Asia: a phase 3, randomised, observer-masked, placebo-controlled trial.","volume":"384","author":"Capeding","year":"2014","journal-title":"Lancet"},{"issue":"2","key":"key-10.2471\/BLT.15.168765-201610311139-R7","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1056\/NEJMoa1411037","article-title":"Efficacy of a tetravalent dengue vaccine in children in Latin America.","volume":"372","author":"Villar","year":"2015","journal-title":"N Engl J Med"},{"issue":"13","key":"key-10.2471\/BLT.15.168765-201610311139-R8","doi-asserted-by":"publisher","first-page":"1195","DOI":"10.1056\/NEJMoa1506223","article-title":"Efficacy and long-term safety of a dengue vaccine in regions of endemic disease.","volume":"373","author":"Hadinegoro","year":"2015","journal-title":"N Engl J Med"},{"key":"key-10.2471\/BLT.15.168765-201610311139-R9","unstructured":"Flasche S, Jit M, Rodriguez-Barraquer I, Coudeville L, Recker M, Koelle K et al. Comparative modelling of dengue vaccine public health impact (CMDVI). Geneva: World Health Organization; 2016. Available from: http:\/\/www.who.int\/immunization\/sage\/meetings\/2016\/april\/2_CMDVI_Report_FINAL.pdf [cited 2016 May 20]."},{"issue":"13","key":"key-10.2471\/BLT.15.168765-201610311139-R10","doi-asserted-by":"publisher","first-page":"1263","DOI":"10.1056\/NEJMe1509442","article-title":"A candidate dengue vaccine walks a tightrope.","volume":"373","author":"Simmons","year":"2015","journal-title":"N Engl J Med"},{"issue":"1","key":"key-10.2471\/BLT.15.168765-201610311139-R11","doi-asserted-by":"publisher","first-page":"71","DOI":"10.21149\/spm.v58i1.7670","article-title":"An\u00e1lisis de la evidencia sobre eficacia y seguridad de la vacuna de dengue CYD-TDV y su potencial registro e implementaci\u00f3n en el Programa de Vacunaci\u00f3n Universal de M\u00e9xico.","volume":"58","author":"Hern\u00e1ndez-\u00c1vila","year":"2016","journal-title":"Salud Publica Mex"},{"issue":"14","key":"key-10.2471\/BLT.15.168765-201610311139-R12","doi-asserted-by":"publisher","first-page":"1643","DOI":"10.1016\/j.vaccine.2016.02.004","article-title":"Protective and immunological behavior of chimeric yellow fever dengue vaccine.","volume":"34","author":"Halstead","year":"2016","journal-title":"Vaccine"},{"key":"key-10.2471\/BLT.15.168765-201610311139-R13","doi-asserted-by":"publisher","first-page":"183","DOI":"10.3389\/fimmu.2014.00183","article-title":"Human immune responses to dengue virus infection: lessons learned from prospective cohort studies.","volume":"5","author":"Endy","year":"2014","journal-title":"Front Immunol"},{"issue":"34","key":"key-10.2471\/BLT.15.168765-201610311139-R14","first-page":"421","article-title":"Addendum to report of the Global Advisory Committee on Vaccine Safety (GACVS), 10-11 June 2015. Safety of CYD-TDV dengue vaccine.","volume":"90","author":"Global Advisory Committee on Vaccine Safety","year":"2015","journal-title":"Wkly Epidemiol Rec"},{"issue":"7","key":"key-10.2471\/BLT.15.168765-201610311139-R15","doi-asserted-by":"publisher","first-page":"1445","DOI":"10.1007\/s00705-013-1645-3","article-title":"Secondary infection as a risk factor for dengue hemorrhagic fever\/dengue shock syndrome: an historical perspective and role of antibody-dependent enhancement of infection.","volume":"158","author":"Guzm\u00e1n","year":"2013","journal-title":"Arch Virol"},{"issue":"9951","key":"key-10.2471\/BLT.15.168765-201610311139-R16","doi-asserted-by":"publisher","first-page":"1327","DOI":"10.1016\/S0140-6736(14)61142-9","article-title":"Dengue vaccines: dawning at last?","volume":"384","author":"Wilder-Smith","year":"2014","journal-title":"Lancet"},{"issue":"2","key":"key-10.2471\/BLT.15.168765-201610311139-R17","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1056\/NEJMe1413146","article-title":"Preventing dengue\u2013is the possibility now a reality?","volume":"372","author":"Thomas","year":"2015","journal-title":"N Engl J Med"},{"issue":"1","key":"key-10.2471\/BLT.15.168765-201610311139-R18","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1038\/nrmicro.2015.2","article-title":"Dengue vaccine: hypotheses to understand CYD-TDV-induced protection.","volume":"14","author":"Guy","year":"2016","journal-title":"Nat Rev Microbiol"},{"issue":"4","key":"key-10.2471\/BLT.15.168765-201610311139-R19","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1586\/14760584.2016.1129279","article-title":"Points for consideration for dengue vaccine introduction - recommendations by the Dengue Vaccine Initiative.","volume":"15","author":"Lim","year":"2016","journal-title":"Expert Rev Vaccines"},{"key":"key-10.2471\/BLT.15.168765-201610311139-R20","unstructured":"Global vaccine safety blueprint. Geneva: World Health Organization; 2012. Available from: http:\/\/extranet.who.int\/iris\/restricted\/bitstream\/10665\/70919\/1\/WHO_IVB_12.07_eng.pdf?ua=1 [cited 2016 Aug 16]."},{"issue":"23","key":"key-10.2471\/BLT.15.168765-201610311139-R21","doi-asserted-by":"publisher","first-page":"2603","DOI":"10.1016\/j.vaccine.2013.03.038","article-title":"Long-term safety assessment of live attenuated tetravalent dengue vaccines: deliberations from a WHO technical consultation.","volume":"31","author":"Bentsi-Enchill","year":"2013","journal-title":"Vaccine"},{"key":"key-10.2471\/BLT.15.168765-201610311139-R22","unstructured":"Technical Advisory Group on Vaccine-Preventable Diseases. Final report of the XXIII Technical Advisory Group (TAG) Meeting on Vaccine-preventable Diseases of the Pan American Health Organization, Varadero, Cuba, 1-3 July 2015. Washington: Pan American Health Organization; 2015. Available from: http:\/\/www.who.int\/immunization\/sage\/meetings\/2015\/october\/5_AMR_2015_TAG_Report_ENG_Final.pdf [cited 2016 May 20]."},{"issue":"19","key":"key-10.2471\/BLT.15.168765-201610311139-R23","doi-asserted-by":"publisher","first-page":"2005","DOI":"10.1001\/jama.2011.650","article-title":"From efficacy to effectiveness in the face of uncertainty: indication creep and prevention creep.","volume":"305","author":"Djulbegovic","year":"2011","journal-title":"JAMA"},{"issue":"9979","key":"key-10.2471\/BLT.15.168765-201610311139-R24","doi-asserted-by":"publisher","first-page":"1726","DOI":"10.1016\/S0140-6736(15)60889-3","article-title":"Differential efficacy of dengue vaccine by immune status.","volume":"385","author":"Rodriguez-Barraquer","year":"2015","journal-title":"Lancet"},{"issue":"8","key":"key-10.2471\/BLT.15.168765-201610311139-R25","doi-asserted-by":"publisher","first-page":"e0004854","DOI":"10.1371\/journal.pntd.0004854","article-title":"Challenges to the design of clinical trials for live-attenuated tetravalent dengue vaccines.","volume":"10","author":"Russell","year":"2016","journal-title":"PLoS Negl Trop Dis"},{"key":"key-10.2471\/BLT.15.168765-201610311139-R26","year":"2015","journal-title":"Evaluaci\u00f3n internacional del programa de vacunaci\u00f3n universal de M\u00e9xico."},{"key":"key-10.2471\/BLT.15.168765-201610311139-R27","year":"2013","journal-title":"Global strategy for dengue prevention and control 2012\u20132020."},{"issue":"1","key":"key-10.2471\/BLT.15.168765-201610311139-R28","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.vaccine.2013.11.066","article-title":"Twenty-five years of the WHO vaccines prequalification programme (1987\u20132012): lessons learned and future perspectives.","volume":"33","author":"Dellepiane","year":"2015","journal-title":"Vaccine"},{"key":"key-10.2471\/BLT.15.168765-201610311139-R29","year":"2015","journal-title":"Global vaccine safety initiative portfolio activities 2012\u20132020."},{"issue":"52","key":"key-10.2471\/BLT.15.168765-201610311139-R30","doi-asserted-by":"publisher","first-page":"7171","DOI":"10.1016\/j.vaccine.2014.10.016","article-title":"Ethical considerations in post-market-approval monitoring and regulation of vaccines.","volume":"32","author":"Thompson","year":"2014","journal-title":"Vaccine"}],"container-title":["Bulletin of the World Health Organization"],"original-title":[],"deposited":{"date-parts":[[2025,3,19]],"date-time":"2025-03-19T17:17:20Z","timestamp":1742404640000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC5096346\/pdf\/BLT.15.168765.pdf"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,9,7]]},"references-count":30,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2016,9,7]]},"published-print":{"date-parts":[[2016,11,1]]}},"URL":"https:\/\/doi.org\/10.2471\/blt.15.168765","relation":{},"ISSN":["0042-9686"],"issn-type":[{"value":"0042-9686","type":"print"}],"subject":[],"published":{"date-parts":[[2016,9,7]]}}}